TABLE 1.
Population | Region(s) | Time period (yr) | Incidence per 100,000 person-years for all S. aureus isolates (incidence for MRSA isolates)a | Reference |
---|---|---|---|---|
All | Denmark | 1957–1990 | 3–20 (NA) | 8 |
Adults ≥21 yr of age | Denmark | 1981–2000 | 18.2–30.5 (NA) | 49 |
All | Denmark | 1995–2008 | 22.7 (0.18) | 9 |
Adults ≥18 yr of age | Iceland | 1995–2008 | 24.5 (0.15) | 25 |
All | Finland | 1995–2001 | 14 (<0.14) | 27 |
All | 7 countries | 2000–2008 | 26.1 (1.9) | 7 |
All | Sweden | 2003–2005 | 33.9 (0) | 55 |
All | Finland | 2004–2007 | 20 (NA) | 50 |
All | Netherlands | 2009 | 19.3 (0.18) | 51 |
All | North Rhine-Westphalia, Germany | 2009 | NA (5.76) | 51 |
Adults ≥18 yr of age | Quebec | 1991–2005 | 24.1–32.4 (0–7.4) | 10 |
Adults ≥18 yr of age | Olmsted County, MN, USA | 1998–2005 | 38.2 (12.4) | 11 |
All | New Zealand | 1998–2005 | 21.5 (0.08) | 26 |
All | Calgary, Canada | 2000–2006 | 19.7 (2.2) | 12 |
All | USA | 2004–2005 | NA (31.8) | 14 |
All, military | USA | 2005–2010 | 4.7 (2) | 29 |
All | NT, Australia | 2006–2007 | 65 (16) | 30 |
All | Australia | 2007–2010 | 11.2 (16) | 31 |
All, CA | Northeast Thailand | 2004–2010 | 2.6 (0.1) | 21 |
Children ≤20 yr of age | Denmark | 1971–2000 | 4.5–8.4 (NA) | 52 |
Children ≤18 yr of age | Calgary | 2000–2006 | 6.5 (0.05) | 53 |
Children <5 yr of age | Kenya | 1998–2002 | 27 (NA) | 22 |
Children <15 yr of age | Mozambique | 2001–2006 | 48 (4.3) | 23 |
Children <5 yr of age | Ghana | 2007–2009 | 630 (105) | 54 |
Children <13 yr of age | South Africa | 2005–2006 | 26 (10) | 24 |
HIV, ≥16 yr of age | Denmark | 1995–2007 | 494 (4.9) | 35 |
HIV, adult | USA | 2000–2004 | 1,960 (850) | 36 |
Hemodialysis | Ireland | 1998–2009 | 17,000 (5,600) | 42 |
All dialysis | Taiwan | 2003–2008 | 1,809 (1,131) | 41 |
NA, not available.